Exact Sciences
EXAS
EXAS was delisted on the 20th of March, 2026.
365 hedge funds and large institutions have $9.04B invested in Exact Sciences in 2018 Q3 according to their latest regulatory filings, with 77 funds opening new positions, 111 increasing their positions, 110 reducing their positions, and 57 closing their positions.
41% more capital invested
Capital invested by funds: $6.41B → $9.04B (+$2.63B)
40% more funds holding in top 10
Funds holding in top 10: 5 → 7 (+2)
35% more first-time investments, than exits
New positions opened: 77 | Existing positions closed: 57
5.62% more ownership
Funds ownership: 87.74% → 93.36% (+5.6%)
5% more funds holding
Funds holding: 349 → 365 (+16)
1% more repeat investments, than reductions
Existing positions increased: 111 | Existing positions reduced: 110
68% less call options, than puts
Call options by funds: $211M | Put options by funds: $667M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$280M |
| 2 |
Ameriprise
Minneapolis,
Minnesota
|
+$163M |
| 3 |
Viking Global Investors
Stamford,
Connecticut
|
+$84.4M |
| 4 |
JP
Jana Partners
New York
|
+$75.9M |
| 5 |
Citigroup
New York
|
+$70.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
D.E. Shaw & Co
New York
|
-$134M |
| 2 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$70.2M |
| 3 |
O
OppenheimerFunds
New York
|
-$68.2M |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$49.9M |
| 5 |
Goldman Sachs
New York
|
-$46.5M |
EXAS Hedge Fund Activity: Q3 2018 in Review
365 of the 4,375 institutional investors tracked by Wall St. Rank reported a position in Exact Sciences (EXAS) for Q3 2018, worth a combined $9.04B — up 41% from $6.41B a quarter earlier.
Buyers outnumbered sellers: 77 funds opened new EXAS positions and 57 closed out — a net gain of 20 holders — while 111 added to existing stakes and 110 trimmed.
The largest buyer was T. Rowe Price Associates, adding an estimated $280M. The largest seller was D.E. Shaw & Co, cutting an estimated $134M.
- 365 institutional investors held Exact Sciences (EXAS) as of Q3 2018, up from 349 in Q2 2018.
- Funds reported $9.04B of Exact Sciences stock for Q3 2018, up 41% quarter-over-quarter.
- 77 funds opened new Exact Sciences positions in Q3 2018 and 57 closed out, a net change of +20 holders.
- The largest Exact Sciences buyer in Q3 2018 was T. Rowe Price Associates, an estimated $280M added.
- The largest Exact Sciences seller in Q3 2018 was D.E. Shaw & Co, an estimated $134M sold.
Based on aggregated 13F filings for Q3 2018.